Literature DB >> 7789059

Risk factors for the development of acute disseminated intravascular coagulation in patients with systemic lupus erythematosus.

Y Shimamoto1, K Suga, A Ohta, M Yamaguchi.   

Abstract

Since acute disseminated intravascular coagulation (DIC) often contributes to a fatal outcome in patients with systemic lupus erythematosus (SLE), prediction of its development is important to prevent the occurrence of such an event. To analyze the risk factor(s) contributing to the development of acute DIC in SLE, we carried out a retrospective study of a series of 129 SLE patients, eight of whom developed DIC during the course of this disease, to assess which of the easily assessable parameters, present at the time of first medical examination, were of predictive significance. The important individual variables, determined by univariate analysis, were male sex, leukopenia, and infection. These factors were placed in a multivariate logistic regression model, and only one factor, infection at first medical examination, was found to have predictive significance for the development of acute DIC in SLE patients. The prevention and control of infection in SLE patients might have implications for preventing the development of acute DIC.

Entities:  

Mesh:

Year:  1995        PMID: 7789059     DOI: 10.1007/bf02214939

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  14 in total

1.  DISEASES OF HYPERSENSITIVITY.

Authors:  D G MCKAY
Journal:  Arch Intern Med       Date:  1965-07

2.  The hematologic aspects of disseminated (systemic) lupus erythematosus.

Authors:  S R MICHAEL; I L VURAL; F A BASSEN; L SCHAEFER
Journal:  Blood       Date:  1951-11       Impact factor: 22.113

3.  The logistic regression analysis of psychiatric data.

Authors:  J L Fleiss; J B Williams; A F Dubro
Journal:  J Psychiatr Res       Date:  1986       Impact factor: 4.791

4.  Acute disseminated intravascular coagulation in systemic lupus erythematosus.

Authors:  A N Whitaker; B T Emmerson
Journal:  Aust N Z J Med       Date:  1972-05

5.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

Review 6.  Disseminated intravascular coagulation and related syndromes: etiology, pathophysiology, diagnosis, and management.

Authors:  R L Bick
Journal:  Am J Hematol       Date:  1978       Impact factor: 10.047

7.  Disseminated intravascular coagulation in lupus erythematosus responding to prednisone therapy.

Authors:  S R Riddell; A M Shojania
Journal:  Am J Hematol       Date:  1986-09       Impact factor: 10.047

8.  Improved or fatal acute disseminated intravascular coagulation in systemic lupus erythematosus.

Authors:  Y Shimamoto; A Ohta; M Sano; K Suga; M Yamaguchi
Journal:  Am J Hematol       Date:  1993-02       Impact factor: 10.047

9.  Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus.

Authors:  E Ginzler; H Diamond; D Kaplan; M Weiner; M Schlesinger; M Seleznick
Journal:  Arthritis Rheum       Date:  1978 Jan-Feb

Review 10.  Disseminated intravascular coagulation in lupus erythematosus with acute liver damage.

Authors:  Y Shimamoto; M Sano; S Kaneda; S Tsunada; K Yamamoto; M Yamaguchi
Journal:  Intern Med       Date:  1992-12       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.